BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18179253)

  • 21. Alpha-synuclein association with phosphatidylglycerol probed by lipid spin labels.
    Ramakrishnan M; Jensen PH; Marsh D
    Biochemistry; 2003 Nov; 42(44):12919-26. PubMed ID: 14596606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.
    Kamiyoshihara T; Kojima M; Uéda K; Tashiro M; Shimotakahara S
    Biochem Biophys Res Commun; 2007 Apr; 355(2):398-403. PubMed ID: 17300751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-synuclein multistate folding thermodynamics: implications for protein misfolding and aggregation.
    Ferreon AC; Deniz AA
    Biochemistry; 2007 Apr; 46(15):4499-509. PubMed ID: 17378587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
    Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
    J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing conformational change of intrinsically disordered α-synuclein to helical structures by distinctive regional interactions with lipid membranes.
    Lee SJ; Lee JW; Choi TS; Jin KS; Lee S; Ban C; Kim HI
    Anal Chem; 2014 Feb; 86(3):1909-16. PubMed ID: 24383916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.
    Du HN; Tang L; Luo XY; Li HT; Hu J; Zhou JW; Hu HY
    Biochemistry; 2003 Jul; 42(29):8870-8. PubMed ID: 12873148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.
    Hoyer W; Cherny D; Subramaniam V; Jovin TM
    Biochemistry; 2004 Dec; 43(51):16233-42. PubMed ID: 15610017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
    Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R
    J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles.
    Zhu M; Qin ZJ; Hu D; Munishkina LA; Fink AL
    Biochemistry; 2006 Jul; 45(26):8135-42. PubMed ID: 16800638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordination of copper to the membrane-bound form of α-synuclein.
    Dudzik CG; Walter ED; Abrams BS; Jurica MS; Millhauser GL
    Biochemistry; 2013 Jan; 52(1):53-60. PubMed ID: 23252394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species.
    Rekas A; Jankova L; Thorn DC; Cappai R; Carver JA
    FEBS J; 2007 Dec; 274(24):6290-304. PubMed ID: 18005258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
    Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
    Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptophan fluorescence reveals structural features of alpha-synuclein oligomers.
    van Rooijen BD; van Leijenhorst-Groener KA; Claessens MM; Subramaniam V
    J Mol Biol; 2009 Dec; 394(5):826-33. PubMed ID: 19837084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway.
    Cappai R; Leck SL; Tew DJ; Williamson NA; Smith DP; Galatis D; Sharples RA; Curtain CC; Ali FE; Cherny RA; Culvenor JG; Bottomley SP; Masters CL; Barnham KJ; Hill AF
    FASEB J; 2005 Aug; 19(10):1377-9. PubMed ID: 15946991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane interaction of α-synuclein in different aggregation states.
    Grey M; Linse S; Nilsson H; Brundin P; Sparr E
    J Parkinsons Dis; 2011; 1(4):359-71. PubMed ID: 23933657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
    Ghee M; Melki R; Michot N; Mallet J
    FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
    Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK
    ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro.
    Kasai T; Tokuda T; Yamaguchi N; Watanabe Y; Kametani F; Nakagawa M; Mizuno T
    Neurosci Lett; 2008 May; 436(1):52-6. PubMed ID: 18358605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.